Drug Shortage Report for TEVA-BUDESONIDE
Report ID | 195478 |
Drug Identification Number | 02465957 |
Brand name | TEVA-BUDESONIDE |
Common or Proper name | TEVA-BUDESONIDE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 0.5MG |
Dosage form(s) | SUSPENSION |
Route of administration | INHALATION INHALATION |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 20 |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-06-19 |
Estimated end date | 2025-09-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-05-02 |
Company comments | Product is under allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v46 | 2025-01-15 | French | Compare |
v45 | 2025-01-15 | English | Compare |
v44 | 2025-01-15 | English | Compare |
v43 | 2024-11-21 | French | Compare |
v42 | 2024-11-21 | English | Compare |
v41 | 2024-11-14 | French | Compare |
v40 | 2024-11-14 | English | Compare |
v39 | 2024-11-01 | French | Compare |
v38 | 2024-11-01 | English | Compare |
v37 | 2024-10-11 | French | Compare |
v36 | 2024-10-11 | English | Compare |
v35 | 2024-09-19 | French | Compare |
v34 | 2024-09-19 | English | Compare |
v33 | 2024-07-26 | French | Compare |
v32 | 2024-07-26 | English | Compare |
v31 | 2024-07-11 | French | Compare |
v30 | 2024-07-11 | English | Compare |
v29 | 2024-05-16 | French | Compare |
v28 | 2024-05-16 | English | Compare |
v27 | 2024-05-09 | French | Compare |